Natera Inc (NTRA)
112.83
+1.74 +1.57%
NASDAQ
Feb 24, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 361.87M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.38 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -188.52M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 47.20% |
| Profit Margin (Quarterly) | -59.43% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 9.632B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 24.55 |
| PE Ratio | -- |
| Price to Book Value | 17.97 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.4664 |
| Free Cash Flow (Quarterly) | -35.07M |
| Return on Equity | Upgrade |
View All NTRA News
News
-
WireHeadlineTime (ET)
-
SA Breaking News02/24 17:35
-
PR Newswire02/23 09:03
-
PR Newswire02/18 09:03
-
MT Newswires02/17 09:39
-
PR Newswire02/17 09:00
-
PR Newswire02/11 09:03
-
Yahoo02/08 07:45
-
PR Newswire02/03 09:03
-
PR Newswire02/01 09:03
-
SA Breaking News01/28 15:56
-
MT Newswires01/28 07:45
-
PR Newswire01/20 15:04
-
PR Newswire01/14 10:35
-
PR Newswire01/12 09:03
-
Yahoo01/09 08:29
-
MT Newswires01/07 12:27
-
PR Newswire01/05 09:03
-
MT Newswires01/04 13:08
-
Yahoo12/29 11:05
-
MT Newswires12/18 10:08
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 02/25/2021 | Earnings | Natera Inc Fourth Quarter Earnings Result for 2020 |
| 02/25/2021 16:30 EST | Misc | Natera Inc Fourth Quarter Earnings Conference Call for 2020 |
| 11/05/2020 | Earnings | Natera Inc Third Quarter Earnings Result for 2020 |
| 11/05/2020 16:30 EST | Misc | Natera Inc Third Quarter Earnings Conference Call for 2020 |
| 08/05/2020 16:30 EDT | Misc | Natera Inc Second Quarter Earnings Conference Call for 2020 |
| 08/05/2020 | Earnings | Natera Inc Second Quarter Earnings Result for 2020 |
| 05/28/2020 11:30 PDT | Misc | Natera Inc Annual General Meeting for 2019 |
| 05/06/2020 16:30 EDT | Misc | Natera Inc First Quarter Earnings Conference Call for 2020 |
| 05/06/2020 | Earnings | Natera Inc First Quarter Earnings Result for 2020 |
| 03/02/2020 | Misc | Natera Inc Annual Report for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.natera.com
- Investor Relations URL: http://investor.natera.com/phoenix.zhtml?c=254055&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Feb. 25, 2021
- Last Earnings Release: Feb. 25, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing genetic features of a fetus. Natera's array of diagnostic services include Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic or a patient for the test upon delivery of the test result.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 112.83 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| GNOM | Global X Genomics & Biotechnology ETF | 4.96% |
| AOFCX | Alger Small Cap Focus C | 4.79% |
| PJHRX | PGIM Jennison Health Sciences R | 3.41% |
| WGFCX | Wells Fargo Growth C | 2.16% |
| DCCRX | Delaware Small Cap Core R | 1.96% |
| JGLYX | JPMorgan Small Cap Growth R4 | 1.72% |
| FKBSX | Federated Hermes Kaufmann Small Cap B | 1.03% |
| XBI | SPDR® S&P Biotech ETF | 0.97% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.56% |
| IWO | iShares Russell 2000 Growth ETF | 0.55% |
| VTWO | Vanguard Russell 2000 ETF | 0.30% |
| IWM | iShares Russell 2000 ETF | 0.30% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NTRA Tweets Stocktwits
Advertisement
